|
Home | Issues | eMJA shop | Classifieds | Contact | More... | Topics | Search | Login | Buy full access |
→ Contents list for this issue
→ More articles on History
→ More articles on Psychiatry
→ More articles on General practice and primary care
→ Search PubMed for related articles
Click to Login
Hide the Login Box
Introduction
—The interview
—Could you say something about your medical training?
—How did the idea of a randomised, placebo controlled trial of antidepressants in general practice come about?
—What was involved in getting the study off the ground?
—What did the study find?
—What was the social context in which the study was conducted?
—What is your view of mental health management in general practice today?
—Competing interests
—Author details
—References
In January 1971, a randomised controlled trial of management of depression by general practitioners was published in the British Medical Journal by Tim Blashki (T G B) and his colleagues Robert Mowbray and Brian Davies (Box 1).1 Although there had been two earlier trials of antidepressants conducted in general practice (one British and one American), this was the first in the world to have extractable data in general-practice-only patients that could be used in a meta-analysis. It is therefore the earliest study included in this year’s published Cochrane Reviews that examines antidepressants versus placebo for depression in primary care; the review’s authors were Bruce Arroll (B A), Grant Blashki (G A B) and colleagues.2
Login or register to purchase access to the full article
|
|
Home | Issues | eMJA shop | Terms of use | Classifieds | More... | Contact | Topics | Search |
©The Medical Journal of Australia 2009 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377
Previous
